UnknownNot Applicable

Suturing With U-Technique Versus Un-Reapproximated Wound Edges During Removal of Closed Thoracostomy Tube Drain

Nigeria142 participantsStarted 2020-01-02

Plain-language summary

The study will be carried out by the principal investigator and his team at the Division of Cardiovascular and Thoracic Surgery of the Department of Surgery, College of Medicine, University of Ibadan and the University College Hospital, Ibadan (UCH), which is the Teaching Hospital of the Medical College.The study sets out to prospectively compare the early and long-term outcomes between the use of purse-string (suturing U-technique) and Un-reapproximated thoracostomy wound edges (Occlusive adhesive-absorbent dressing application) at the time of removal of thoracostomy tube drain in patients who have had chest tube insertion.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Pleural effusion
. Traumatic or spontaneous pneumothorax
. Traumatic haemothorax
. As an adjunct to a thoracotomy for a non-neoplastic and or non -infective condition

Exclusion criteria

. An associated pyopneumothorax
. Cancer encuirasse of the chest wall
. Unconscious with unclear consent situation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of participants with Proportion of clinical and wound complications with indwelling chest tube - SEVERE PAIN

Timeframe: It will span the period from chest tube insertion till chest tube removal

Number of participants with clinical and wound complications with indwelling chest tube- TUBE DISLODGEMENT

Timeframe: It will span the period from chest tube insertion till chest tube removal

Number of participants with clinical and wound complications with indwelling chest tube - PERITUBAL LEAKAGE

Timeframe: It will span the period from chest tube insertion till chest tube removal

Number of participants with early wound complications after chest tube removal- AIR SUCK-IN

Timeframe: It will span the period from chest tube removal till the patient is discharged home after chest tube removal

Number of participants with early wound complications after chest tube removal- POST-INSERTION WOUND INFECTION

Timeframe: It will span the period from chest tube removal till the patient is discharged home after chest tube removal

Number of participants with early wound complications after chest tube removal- WOUND DEHISCENCE

Trial details

NCT IDNCT04193241

SponsorUniversity of Ibadan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

Contact for this trial

Lateef A Baiyewu, MD,FWACS

+234 80 34455695 bayan_latyph@yahoo.com

View on ClinicalTrials.gov More Pleural Effusion trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Pleural effusion
. Traumatic or spontaneous pneumothorax
. Traumatic haemothorax
. As an adjunct to a thoracotomy for a non-neoplastic and or non -infective condition

Exclusion criteria

. An associated pyopneumothorax
. Cancer encuirasse of the chest wall
. Unconscious with unclear consent situation